DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017 年 10 月 18 日 7:00 上午 - 2017 年 10 月 19 日 10:00 下午

1750 Rockville Pike, , Rockville, MD 20852 , USA

Metrics in Patient-Centered Drug Development Conference

Session 7: Case Examples of the Impact of Engagement

Session Chair(s)

Stella  Stergiopoulos, MPH, MS

Stella Stergiopoulos, MPH, MS

Director, Health Economic and Outcomes Research

EQRx, United States

The relationship of patient-centered initiatives to improvements in the drug development process and its outcomes can be difficult to pinpoint due to the complexity of the process and the many factors that also have an impact. Structured approaches to assessing the impact of these initiatives and broad dissemination of the results are key to validating the value of patient-centered practices in drug development. This session will explore case examples of patient-centered interventions that resulted in improved outcomes for stakeholders in the drug product life cycle. Presenters will share their experiences with implementing and evaluating a patient-centered initiative: What outcome objectives did they set? How did these influence plans for the patient-centered intervention? How was success defined and what measures were constructed? How did the implementation experience and results inform future work?

Learning Objective :
  • Suggest metrics that could inform improvements in patient-centered approaches in the case examples
  • Identify the expected impact of a patient-centered initiative in planning or in implementation within his or her project or organization
  • Describe project elements that could be quantified or measured to demonstrate impact of the patient feedback on the process or final outcome
  • Speaker(s)

    Mary  Short, MSN, RN

    Speaker

    Mary Short, MSN, RN

    Eli Lilly and Company, United States

    Sr. Research Advisor, Clinical, MDU, Medical Pediatric Capabilities

    Elizabeth  Turcotte, MBA

    Speaker

    Elizabeth Turcotte, MBA

    Bristol-Myers Squibb, United States

    Director, Patient Hub

    Debra  Reinhard

    Speaker

    Debra Reinhard

    Bristol-Myers Squibb, United States

    Head, Translational Medicine Enabling Solutions

    Carrie  Corboy, PharmD, RPh

    Speaker

    Carrie Corboy, PharmD, RPh

    Janssen Global Services, United States

    Senior Director, Standards & Execution Excellence

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。